{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T22:08:45Z","timestamp":1766441325392,"version":"build-2065373602"},"reference-count":15,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ajicjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Infection Control"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.ajic.2021.10.017","type":"journal-article","created":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T13:09:16Z","timestamp":1635426556000},"page":"8-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Side effects of messenger RNA vaccines and prior history of COVID-19, a cross-sectional study"],"prefix":"10.1016","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4105-7743","authenticated-orcid":false,"given":"Renuka Ananth Kalyan","family":"Kadali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravali","family":"Janagama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7510-9110","authenticated-orcid":false,"given":"Siva H.","family":"Yedlapati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1519-5045","authenticated-orcid":false,"given":"Neelakanta","family":"Kanike","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viswanath","family":"Gajula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajasekhar R.","family":"Madathala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swati","family":"Poddar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neelakanta","family":"Sukka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9965-9638","authenticated-orcid":false,"given":"Hanumantha R.","family":"Jogu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shailaja","family":"Racherla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isha","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajic.2021.10.017_bib0001","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1001\/jama.2020.24865","article-title":"COVID-19 as the leading cause of death in the United States","volume":"325","author":"Woolf","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.ajic.2021.10.017_bib0002","unstructured":"NVSS - provisional death counts for COVID-19 - executive summary. https:\/\/www.cdc.gov\/nchs\/covid19\/mortality-overview.htm. Accessed June 30, 2021."},{"key":"10.1016\/j.ajic.2021.10.017_bib0003","first-page":"372:n83","article-title":"Are overwhelmed health systems an inevitable consequence of Covid-19? Experiences from China, Thailand, and New York State","author":"Tangcharoensathien","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.ajic.2021.10.017_bib0004","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajic.2021.10.017_bib0005","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajic.2021.10.017_bib0006","unstructured":"CDC. Interim clinical considerations for use of COVID-19 vaccines currently authorized in the United States. https:\/\/www.cdc.gov\/vaccines\/covid-19\/clinical-considerations\/covid-19-vaccines-us.html#Appendix-C. Accessed June 30, 2021"},{"key":"10.1016\/j.ajic.2021.10.017_bib0007","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ijid.2021.04.047","article-title":"Side effects of BNT162b2 mRNA COVID-19 vaccine: a randomized, cross-sectional study with detailed self-reported symptoms from healthcare workers","volume":"106","author":"Kadali","year":"2021","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ajic.2021.10.017_bib0008","doi-asserted-by":"crossref","first-page":"4420","DOI":"10.1002\/jmv.26996","article-title":"Non-life-threatening adverse effects with COVID-19 mRNA-1273 vaccine: a randomized, cross-sectional study on healthcare workers with detailed self-reported symptoms","volume":"93","author":"Kadali","year":"2021","journal-title":"J Med Virol"},{"key":"10.1016\/j.ajic.2021.10.017_bib0009","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.ajog.2021.06.007","article-title":"Adverse effects of COVID-19 messenger RNA vaccines among pregnant women: a cross-sectional study on healthcare workers with detailed self-reported symptoms","volume":"225","author":"Kadali","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajic.2021.10.017_bib0010","first-page":"70","article-title":"First month of COVID-19 vaccine safety monitoring \u2014 United States, December 14, 2020\u2013January 13","volume":"2021","author":"Gee","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ajic.2021.10.017_bib0011","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1001\/jama.2021.5374","article-title":"Reactogenicity following receipt of mRNA-Based COVID-19 vaccines","volume":"325","author":"Chapin-Bardales","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.ajic.2021.10.017_bib0012","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3390\/life11030249","article-title":"Self-reported real-world safety and reactogenicity of COVID-19 vaccines: a vaccine recipient survey","volume":"11","author":"Mathioudakis","year":"2021","journal-title":"Life"},{"key":"10.1016\/j.ajic.2021.10.017_bib0013","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1056\/NEJMc2101667","article-title":"Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine","volume":"384","author":"Krammer","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajic.2021.10.017_bib0014","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1001\/jama.2021.3341","article-title":"Binding and Neutralization Antibody Titers after a Single Vaccine Dose in Health Care Workers Previously Infected with SARS-CoV-2","volume":"325","author":"Saadat","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.ajic.2021.10.017_bib0015","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.jaip.2020.12.047","article-title":"mRNA vaccines to prevent COVID-19 disease and reported allergic reactions: current evidence and suggested approach","volume":"9","author":"Banerji","year":"2021","journal-title":"J Allergy Clin Immunol Pract"}],"container-title":["American Journal of Infection Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019665532100688X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019665532100688X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T05:57:11Z","timestamp":1759298231000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S019665532100688X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S019665532100688X"],"URL":"https:\/\/doi.org\/10.1016\/j.ajic.2021.10.017","relation":{},"ISSN":["0196-6553"],"issn-type":[{"type":"print","value":"0196-6553"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Side effects of messenger RNA vaccines and prior history of COVID-19, a cross-sectional study","name":"articletitle","label":"Article Title"},{"value":"American Journal of Infection Control","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajic.2021.10.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Inc. on behalf of Association for Professionals in Infection Control and Epidemiology, Inc.","name":"copyright","label":"Copyright"}]}}